Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M. Bryan Reasons

Affiliations

  • Director at Aclaris Therapeutics Inc. (ACRS), 2019-06-10
  • Evp & Cfo at Mallinckrodt Plc (MNK), 2019-06-07
  • Director at Recro Pharma Inc. (REPH), 2019-05-10
  • Cfo at Amneal Pharmaceuticals Inc. (AMRX), 2018-08-23
  • Chief Financial Officer at Impax Laboratories Llc (IPXL), 2018-05-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MNK $8.96 5,400 Officer 17,979 2019-06-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AMRX $23.65 11,698 Officer 82,986 2018-08-21 Filing